- Home
- MTEK vs RDHL Comparison
MTEK vs RDHL Comparison
Compare MTEK & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEK
- RDHL
- Stock Information
- Founded
- MTEK 2008
- RDHL 2009
- Country
- MTEK Israel
- RDHL Israel
- Employees
- MTEK N/A
- RDHL N/A
- Industry
- MTEK
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- MTEK
- RDHL Health Care
- Exchange
- MTEK Nasdaq
- RDHL Nasdaq
- Market Cap
- MTEK N/A
- RDHL 4.3M
- IPO Year
- MTEK 2022
- RDHL N/A
- Fundamental
- Price
- MTEK $3.26
- RDHL $2.10
- Analyst Decision
- MTEK
- RDHL
- Analyst Count
- MTEK 0
- RDHL 0
- Target Price
- MTEK N/A
- RDHL N/A
- AVG Volume (30 Days)
- MTEK 163.9K
- RDHL 18.8K
- Earning Date
- MTEK 08-27-2025
- RDHL 08-28-2025
- Dividend Yield
- MTEK N/A
- RDHL N/A
- EPS Growth
- MTEK N/A
- RDHL N/A
- EPS
- MTEK N/A
- RDHL N/A
- Revenue
- MTEK $6,078,953.00
- RDHL $8,042,999.00
- Revenue This Year
- MTEK N/A
- RDHL $381.91
- Revenue Next Year
- MTEK N/A
- RDHL N/A
- P/E Ratio
- MTEK N/A
- RDHL N/A
- Revenue Growth
- MTEK 50.80
- RDHL 23.17
- 52 Week Low
- MTEK $1.45
- RDHL $1.71
- 52 Week High
- MTEK $6.47
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- MTEK 61.92
- RDHL 61.27
- Support Level
- MTEK $3.00
- RDHL $2.00
- Resistance Level
- MTEK $3.28
- RDHL $2.08
- Average True Range (ATR)
- MTEK 0.34
- RDHL 0.09
- MACD
- MTEK 0.00
- RDHL 0.03
- Stochastic Oscillator
- MTEK 53.45
- RDHL 100.00
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.